IVF Stock Forecast: INVO Fertility, Inc. Price Predictions for 2026-2027
Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 29 of 100 as at 21 Nov 2026 — in the lower half.
One number for the whole business
Consensus tells you what everyone already believes. The model scores INVO Fertility, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Growth (97): Sales and profits are climbing, and climbing faster than before.
Value (15): The shares cost a lot relative to the profits and assets behind them.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
IVF stock forecast 2026-2027: analyst price targets & predictions
The bullish and bearish analyst opinions on IVF, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
This page is one stock. Monday covers all of them.
IVF appears in the Radar on the weeks it earns a place.
- Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
- The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and servers
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
IVF vs the S&P 500
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 20 Nov 2026, INVO Fertility, Inc. returned −96.4% against +6.9% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
IVF analyst estimate revisions
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
Financials
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
- Trailing P/E
- 0.0×
- Price / sales
- 0.3×
- Price / book
- 0.1×
- EV / EBITDA
- —
Cheaper than 99% of US stocks
Cheaper than 88% of US stocks
Cheaper than 95% of US stocks
- Revenue growth (YoY)
- —
- Earnings growth (YoY)
- —
- Gross margin
- 35.1%
- Operating margin
- −72.2%
- Net margin
- —
Higher than 42% of US stocks
Higher than 16% of US stocks
- Return on equity
- −54.1%
- Return on assets
- −16.3%
- Dividend yield
- —
Higher than 21% of US stocks
Higher than 22% of US stocks
Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.
Key statistics
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
INVO Fertility, Inc. has a market value of $2.1M and an enterprise value of $1.9M.
Revenue in the twelve months to 30 June 2026: $7.5M. The latest quarter grew 16.7% year on year.
Net income over the same four quarters: −$5.3M, a −70.2% net margin.
Free cash flow in the twelve months to 30 June 2026: −$4.8M.
INVO Fertility, Inc. spent $0.0 on share buybacks in the twelve months to 30 June 2026.
Trailing P/E: 0.0×.
INVO Fertility, Inc. employs 40 people — $188K of revenue per employee.
Data provided by Twelve Data
IVF and its peers
The nearest names by industry and size, scored by the same model — like for like.
Take a look at IVF’s peer groups, ranked by the model: healthcare stocks.
Look up any of the roughly 4,300 stocks we score.
The rank is the raw material. Whether the rules would actually own INVO Fertility, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
Questions about IVF
How does Ticker Nerd's model rank IVF?
As at 21 Nov 2026, INVO Fertility, Inc. ranks 29 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (97 of 100).
What is the IVF stock forecast for 2030?
No analyst covering INVO Fertility, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for IVF are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $80 to $80 over the next 12 months.
How has IVF stock performed over the past year?
INVO Fertility, Inc. returned -96.4% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
What does INVO Fertility, Inc. do?
INVO Fertility Inc. is a healthcare services company focused on assisted reproductive technology and women’s fertility care. The company operates fertility clinics and related service offerings that support patients seeking infertility treatment, including in vitro fertilization and the intravaginal culture procedure enabled by its INVOcell medical device.
About INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services company focused on assisted reproductive technology and women’s fertility care. The company operates fertility clinics and related service offerings that support patients seeking infertility treatment, including in vitro fertilization and the intravaginal culture procedure enabled by its INVOcell medical device. INVO Fertility also commercializes INVOcell for use in third-party clinics, extending its technology platform beyond owned locations. Its business is centered on making fertility treatment more accessible through a combination of clinic operations, proprietary devices, and patient-centered care delivery. Headquartered in Sarasota, Florida, INVO Fertility serves the reproductive health market with a model that blends medical technology and clinical services.
CEO Mr. Steven M. Shum · 40 employees · United States · https://www.invofertility.com